Joseph J. Sarret, MD, JD
Joseph J. Sarret, M.D., J.D., is Chief Executive Officer and Director of CohBar Inc., (NASDAQ: CWBR), a clinical stage biotechnology company focused on the research and development of mitochondria based therapeutics, an emerging class of drugs for the treatment of chronic and age-related diseases. He can be reached at: [email protected]
Advice For New CEOs During The Pandemic
Taking the top job under the best of circumstances is no easy feat—for this CEO, doing it during a global pandemic added some unexpected hurdles. Here's how he managed.
- Advertisement -
- Advertisement -
FEATURED CONTENT
New Poll: CEOs Find Challenges In Using Customer Data To Drive Innovation
Ability to harness and sort through data for meaningful insights remains a hurdle, many say. “The key is...finding what is actually relevant.”
SUBSCRIBE TO CHIEF EXECUTIVE
Sign Up to Receive Chief Executive Magazine
Chief Executive’s publications are designed to help CEOs do their jobs better and run their businesses more effectively. Subscribe here.
CEO CONFIDENCE INDEX
In Poll, Majority of CEOs Say Hybrid Work Is Here to Stay for 2022. Full Virtual? Not so Much
Almost all the CEOs we surveyed in May say they will work in at least partially hybrid mode for the rest of the year—versus just 7 percent who said they'd be fully remote.